Comment on l'Ami et al titled 'Successful reduction of overexposure in patients with rheumatoid arthritis with high serum adalimumab concentrations: an open-label, non-inferiority, randomised clinical trial'
SourceAnnals of the Rheumatic Diseases, 77, 10, (2018), pp. e67
Article / Letter to editor
Display more detailsDisplay less details
Annals of the Rheumatic Diseases
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.